Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Investigators at University of Kentucky, Medical Department have published new data on breast cancer
March 12th, 2009
"Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a member of the nuclear hormone receptor superfamily and is highly expressed in many human tumors including breast cancer. PPAR gamma has been identified as a potential target for breast cancer therapy based on the fact that its activation by synthetic ligands affects the differentiation, proliferation, and apoptosis of cancer cells," investigators in the United States report. "However, the controversial nature of current studies and disappointing results from clinical trials raise questions about the contribution of PPAR gamma signaling in breast cancer development in the absence of stimulation by...
Source: Women's Health Weekly (2009-03-12)
|
